MSB 1.50% $1.18 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1071

  1. 1,896 Posts.
    lightbulb Created with Sketch. 490
    I've got a whisper for ya.

    I heard that the FDA suggested there is sufficient data for approval and that the company intends to file this quarter and expects a 2-month turn around.

    Don't remember where I heard that.... Maybe it was in an article or an announcement or 2.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.018(1.50%)
Mkt cap ! $1.318B
Open High Low Value Volume
$1.15 $1.20 $1.15 $3.829M 3.276M

Buyers (Bids)

No. Vol. Price($)
36 90649 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.19 58589 7
View Market Depth
Last trade - 15.40pm 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.